Literature DB >> 14747396

Vascular access and all-cause mortality: a propensity score analysis.

Kevan R Polkinghorne1, Stephen P McDonald, Robert C Atkins, Peter G Kerr.   

Abstract

The native arteriovenous fistula (AVF) is the preferred vascular access because of its longevity and its lower rates of infection and intervention. Recent studies suggest that the AVF may offer a survival advantage. Because these data were derived from observational studies, they are prone to potential bias. The use of propensity scores offers an additional method to reduce bias resulting from nonrandomized treatment assignment. Adult (age 18 yr or more) patients who commenced hemodialysis in Australia and New Zealand on April 1, 1999, until March 31, 2002, were studied by using the Australian and New Zealand Dialysis and Transplant Association (ANZDATA) Registry. Cox regression was used to determine the effect of access type on total mortality. Propensity scores were calculated and used both as a controlling variable in the multivariable model and to construct matched cohorts. The catheter analysis was stratified by dialysis duration at entry to ANZDATA to satisfy the proportional-hazard assumption. There were 612 deaths in 3749 patients (median follow-up, 1.07 yr). After adjustment for confounding factors and propensity scores, catheter use was predictive of mortality. Patients with arteriovenous grafts (AVG) also had a significantly increased risk of death. Effect estimates were also consistent in the smaller propensity score-matched cohorts. Both AVG and catheter use in incident hemodialysis patients are associated with significant excess of total mortality. Reducing catheter use and increasing the proportion of patients commencing hemodialysis with a mature AVF remain important clinical objectives.

Entities:  

Mesh:

Year:  2004        PMID: 14747396     DOI: 10.1097/01.asn.0000109668.05157.05

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  104 in total

1.  The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.

Authors:  Krishna Poinen; Robert R Quinn; Matthew J Oliver; Daniel Devoe; Rameez Kabani; Fareed Kamar; Priyanka Mysore; Adriane M Lewin; Swapnil Hiremath; Jennifer MacRae; Matthew T James; Lisa Miller; Brenda R Hemmelgarn; Louise M Moist; Amit X Garg; Tanvir T Chowdhury; Pietro Ravani
Journal:  J Am Soc Nephrol       Date:  2016-10-06       Impact factor: 10.121

2.  Relationship between dialysis modality and mortality.

Authors:  Stephen P McDonald; Mark R Marshall; David W Johnson; Kevan R Polkinghorne
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

3.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

4.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

Review 5.  Associations between hemodialysis access type and clinical outcomes: a systematic review.

Authors:  Pietro Ravani; Suetonia C Palmer; Matthew J Oliver; Robert R Quinn; Jennifer M MacRae; Davina J Tai; Neesh I Pannu; Chandra Thomas; Brenda R Hemmelgarn; Jonathan C Craig; Braden Manns; Marcello Tonelli; Giovanni F M Strippoli; Matthew T James
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

6.  Comparison of complications and dialysis adequacy between temporary and permanent tunnelled catheter for haemodialysis.

Authors:  Nihad Kukavica; Halima Resic; Vahidin Sahovic
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

7.  Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Authors:  Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum
Journal:  Am J Nephrol       Date:  2018-08-02       Impact factor: 3.754

8.  Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimise complications (Timely PD study).

Authors:  Dwarakanathan Ranganathan; Richard Baer; Robert G Fassett; Nicola Williams; Thin Han; Melanie Watson; Helen Healy
Journal:  BMC Nephrol       Date:  2010-06-22       Impact factor: 2.388

9.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.